ABP-006

N/A

Report date: 2025/01/26 15:12:16

NME

Base Information

Drug NameABP-006

Drug Alias Nametopoisomerase I inhibitor-hyaluronic acid complex (Aluron Biopharma)ABP-006

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA topoisomerase I inhibitors

TargetsDNA topoisomerase I

Therapy Area/IndicationsColonic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsColonic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A